QQ客服 官方微博 反馈留言

浏览/检索结果: 共13条，第1-10条 帮助 限定条件 发表日期：2017     已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 Impact of antiviral therapy on the peripheral Th17/Treg cytokines and specific transcription factor (RORγt, Foxp3) in patients with HBeAg positive chronic hepatitis B 期刊论文 Hepatology International, 2017, 卷号: 11 作者:  Ding J., You J., Chen Y.H., Liu E.H., Wang T.H., Zhang Y.R., Jin Z., Xu F., Jia H.G. 收藏  |  浏览/下载：5/0  |  提交时间：2019/12/04 Study of peginterferon alpha treatment in 210 HBeAg-positive chronic hepatitis B patients 期刊论文 Hepatology International, 2017, 卷号: 11 作者:  Wu L., Mei G.X., Jun Z.S., Qin P., Ling Z.X., Yan M.C., Yan Z.J. 收藏  |  浏览/下载：3/0  |  提交时间：2019/12/04 Serum hepatitis B virus RNA levels as a predictor of HBeAg seroconversion during treatment with peginterferon alfa-2a in hepatitis B e antigen-positive patients 期刊论文 Hepatology International, 2017, 卷号: 11 作者:  Jia W., Zhu M.Q., Zhang J.M. 收藏  |  浏览/下载：3/0  |  提交时间：2019/12/05 Addition of (pegylated) interferon to entecavir increases response in treatment naive HBeAg-positive patients with chronic hepatitis B 会议论文 作者:  Liem, S.;  van Campenhout, M. J.;  Chi, H.;  Brouwer, W. P.;  Xie, Q. 收藏  |  浏览/下载：12/0  |  提交时间：2019/12/05 Correlation between serum HBV RNA, HBV DNA, HBsAg, HBeAg and intrahepatic cccDNA at baseline and 96 weeks after nucleos(t)ide analogues treatment in HBeAg-positive patients with chronic HBV infection 期刊论文 Hepatology International, 2017, 卷号: 11 作者:  Gao Y., Li Y., Meng Q., Zhang Z., Zhao P., Shang Q., Li Y., Su M., Liu X., Li T., Zhuang H. 收藏  |  浏览/下载：3/0  |  提交时间：2019/12/05 Serum HBV RNA level predicts response to peginterferon add-on therapy for HBeAg-positive chronic hepatitis B 会议论文 作者:  van Campenhout, Margo J. y;  van Bommel, Florian;  Brouwer, Willem Pieter;  Xie, Qing;  Zhang, Qin 收藏  |  浏览/下载：2/0  |  提交时间：2019/12/05 PEG-IFN stepwise optimization treatment strategy improve efficacy for PEG-IFN early suboptimal response patients in HBeAg positive chronic hepatitis B 期刊论文 Hepatology International, 2017, 卷号: 11 作者:  Pu Z., Yang F., Gu J., Huang Y., Zhang J. 收藏  |  浏览/下载：9/0  |  提交时间：2019/12/05 Pegylated Interferon Alfa-2b Add-on Treatment in Hepatitis B Virus Envelope Antigen-Positive Chronic Hepatitis B Patients Treated with Nucleos(t) ide Analogue: A Randomized, Controlled Trial (PEGON) 期刊论文 JOURNAL OF INFECTIOUS DISEASES, 2017, 卷号: 215, 期号: 7 作者:  Chi, Heng;  Hansen, Bettina E.;  Guo, Simin;  Zhang, Ning Ping;  Qi, Xun 收藏  |  浏览/下载：15/0  |  提交时间：2019/12/05 Antiviral therapy  HBeAg seroconversion  combination therapy  interferon naive   Effectiveness of peginterferon Alfa-2a (40KD) therapy in HBeAg-positive chinese patients with chronic hepatitis B at 3 years post-treatment: Sub-analysis of the prospective, global, observational S-collate study 期刊论文 Hepatology International, 2017, 卷号: 11 作者:  Xie Q., Xie Y., Chen X., Chen X., Chen Y., Zhang J., Ren H., Zhang H., Tang H., Wei L., Wang X., Castillo M., Hou M. 收藏  |  浏览/下载：1/0  |  提交时间：2019/12/05 Clinical effect and safety of 144-week treatment with entecavir capsules in treatment-naïve HBeAg-positive patients with chronic hepatitis B]. 期刊论文 Chinese journal of hepatology, 2017, 卷号: 25, 页码: 597-600 作者:  Cai D C;  Pan C;  Yu W H;  Dang S S;  Li J 收藏  |  浏览/下载：3/0  |  提交时间：2019/11/26 Entecavir capsule  Safety  Efficacy